Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    0.00 (0.00%)
Bid:
4,300.00
Ask:
6,245.00
Spread: 1,945.00 (45.233%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

9 Nov 2021 07:00

RNS Number : 7218R
DCC PLC
09 November 2021
 

 

9 November 2021

Board Changes

 

Appointment of New Non-Executive Director

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Mr. Alan Ralph as a non-executive Director and member of the Audit Committee with effect from 8 November 2021.

Mr. Ralph is a very experienced business and finance leader having spent almost 20 years with UDG Healthcare plc (formerly United Drug plc). Mr. Ralph spent ten years leading UDG's largest business unit before supporting its strategic transformation as Chief Financial Officer for five years. Mr. Ralph is a Chartered Accountant.

There are no details to be disclosed under Listing Rule 9.6.13 in respect of Mr. Ralph.

Appointment of Workforce Engagement Director

Mr. Mark Ryan, who has been a non-executive Director since November 2017, has been appointed as the designated Director for engagement with the workforce, succeeding Mr. Cormac McCarthy who passed away in July 2021. Mr. Ryan has also been appointed as a member of the Governance and Sustainability Committee. Both appointments take effect from 8 November 2021.

Mark Breuer, Chairman of DCC plc, said:

"I warmly welcome Alan Ralph to the Board. His financial expertise, business leadership experience and knowledge of the healthcare sector will enhance the Board's knowledge in several key areas."

"I am also very pleased that Mark Ryan will take on the important role of workforce engagement Director. Mark has been a valued member of the Board since 2017 and will bring his knowledge of DCC and extensive business experience to the position."

Contact information 

Investor enquiries:

Darragh Byrne, Company Secretary

Rossa White, Head of Group Investor Relations

Tel: +353 1 2799 400

Email: investorrelations@dcc.ie

 

 

Media enquiries:

Powerscourt (Eavan Gannon/Victoria Palmer Moore)

Tel: +44 20 7250 1446

Email: DCC@powerscourt-group.com

 

 

DCC website:

www.dcc.ie

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABPBLTMTTMBMB
Date   Source Headline
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20253:11 pmRNSHolding in Company TR-1
11th Jun 202510:00 amRNS2025 Annual Report, Notice of AGM and Proxy Form
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20255:20 pmRNSTotal Voting Rights
30th May 20255:00 pmRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSLaunch of £100 million Share Buyback Programme
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding
12th Nov 20247:01 amRNSResults for the six months ended 30 September 2024
12th Nov 20247:00 amRNSStrategy Update: DCC to focus on Energy sector
20th Aug 20245:52 pmRNSHolding in Company TR-1
31st Jul 20242:20 pmRNSTotal Voting Rights
11th Jul 20244:53 pmRNSResult of AGM
11th Jul 20247:02 amRNSBoard Appointment
11th Jul 20247:01 amRNSDivestment of Hong Kong Energy Business
11th Jul 20247:00 amRNSAGM Trading Statement
12th Jun 202410:09 amRNS2024 Sustainability Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.